These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9085963)

  • 1. Nalbuphine coadministered with morphine prevents tolerance and dependence.
    Lee SC; Wang JJ; Ho ST; Tao PL
    Anesth Analg; 1997 Apr; 84(4):810-5. PubMed ID: 9085963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of morphine tolerance and withdrawal syndrome by coadministration of nalbuphine.
    Jang S; Kim H; Kim D; Jeong MW; Ma T; Kim S; Ho IK; Oh S
    Arch Pharm Res; 2006 Aug; 29(8):677-84. PubMed ID: 16964763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic co-administration of nalbuphine attenuates the development of opioid dependence.
    Raghav R; Jain R; Dhawan A; Roy TS; Kumar P
    Pharmacol Biochem Behav; 2018 Dec; 175():130-138. PubMed ID: 30312633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vasopressin on the effect of U-50,488 to block the development of morphine tolerance and physical dependence.
    Tao PL; Liu WC; Tsuei YS; Cheng CY
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):281-7. PubMed ID: 9050024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
    Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
    Ibuki T; Dunbar SA; Yaksh TL
    Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice.
    Shin EJ; Jang CG; Bing G; Park DH; Oh CH; Koo KH; Oh KW; Yamada K; Nabeshima T; Kim HC
    Drug Alcohol Depend; 2009 Sep; 104(1-2):175-84. PubMed ID: 19559544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs.
    Tao PL; Hwang CL; Chen CY
    Eur J Pharmacol; 1994 May; 256(3):281-6. PubMed ID: 8045272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
    Suzuki T; Narita M; Takahashi Y; Misawa M; Nagase H
    Eur J Pharmacol; 1992 Mar; 213(1):91-7. PubMed ID: 1499660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat.
    Friese N; Diop L; Lambert C; Rivière PJ; Dahl SG
    Life Sci; 1997; 61(16):1559-70. PubMed ID: 9353165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL; Huang EY; Chow LH; Tao PL
    Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowly Signaling G Protein-Biased CB
    Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
    Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
    McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
    Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent chronic escalating morphine administration induces long lasting changes in tolerance and dependence to morphine in rats.
    Salmanzadeh H; Azizi H; Semnanian S
    Physiol Behav; 2017 May; 174():191-196. PubMed ID: 28302576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.